These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1171032

  • 1. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S, Takemura Y, Ieiri T, Kasai K, Kikuchi T.
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan 20; 51(1):9-17. PubMed ID: 1171032
    [Abstract] [Full Text] [Related]

  • 2. Effect of glucose on the growth hormone response to L-dopa in normal and diabetic subjects.
    Ajlouni K, Martinson DR, Hagen TC.
    Diabetes; 1975 Jul 20; 24(7):633-6. PubMed ID: 1158029
    [Abstract] [Full Text] [Related]

  • 3. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A.
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug 20; 51(8):676-84. PubMed ID: 1237421
    [Abstract] [Full Text] [Related]

  • 4. [The inhibitory effect of tolbutamide on both secretions of cortisol in the adrenal cortex and of prolactin in the pituitary gland (author's transl)].
    Hoshino R.
    Nihon Naibunpi Gakkai Zasshi; 1980 May 20; 56(5):707-23. PubMed ID: 6248384
    [Abstract] [Full Text] [Related]

  • 5. Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects.
    Laurian L, Oberman Z, Ayalon D, Cordova T, Herzberg M, Horer E, Harell A.
    Isr J Med Sci; 1975 May 20; 11(5):482-7. PubMed ID: 1158662
    [Abstract] [Full Text] [Related]

  • 6. [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].
    Schönberger W, Ziegler R, Brodt B, Grimm W.
    Eur J Pediatr; 1976 Jun 08; 122(3):195-200. PubMed ID: 1278188
    [Abstract] [Full Text] [Related]

  • 7. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I, Vigas M, Jurcovicová J, Repceková D, Kolesár P.
    Diabetes; 1978 Apr 08; 27(4):396-9. PubMed ID: 640244
    [Abstract] [Full Text] [Related]

  • 8. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A, De Marinis L, Martino F.
    J Endocrinol Invest; 1978 Jul 08; 1(3):259-61. PubMed ID: 756876
    [Abstract] [Full Text] [Related]

  • 9. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May 08; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 10. Secretion of human growth hormone and insulin in levodopa test during carbamazepine therapy.
    Syvälahti E, Pynnönen S.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb 08; 40(2):285-8. PubMed ID: 320826
    [Abstract] [Full Text] [Related]

  • 11. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B, Reiner Z, Sekso M.
    Exp Clin Endocrinol; 1983 Jan 08; 81(1):41-8. PubMed ID: 6343098
    [Abstract] [Full Text] [Related]

  • 12. [Response of growth hormone (HGH) to L-dopa, L-arginine and their combination in normal individuals].
    Hernández Armas J, González García C, Rodríguez I.
    Med Clin (Barc); 1983 Jan 08; 79(8):365-9. PubMed ID: 6757593
    [No Abstract] [Full Text] [Related]

  • 13. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K, Aida M, Tano T, Yoshinaga K.
    Tohoku J Exp Med; 1977 Mar 08; 121(3):197-206. PubMed ID: 404727
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.
    Boden G, Soeldner JS, Gleason RE, Marble A.
    J Clin Invest; 1968 Apr 08; 47(4):729-39. PubMed ID: 5641614
    [Abstract] [Full Text] [Related]

  • 15. Dopaminergic stimulation of HGH in diabetes mellitus and in obesity.
    Gragnoli G, Palazzuoli V, Favilli R, Tanganelli I, Migliarese G.
    Acta Diabetol Lat; 1977 Apr 08; 14(3-4):137-43. PubMed ID: 605744
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
    Vigas M, Klimes I, Jurcovicova J, Kolesar P, Repcekova-Jezova D.
    Diabete Metab; 1977 Dec 08; 3(4):257-8. PubMed ID: 598566
    [Abstract] [Full Text] [Related]

  • 17. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Tanaka K, Inoue S, Numata K, Okazaki H, Nakamura S, Takamura Y.
    Metabolism; 1990 Sep 08; 39(9):892-6. PubMed ID: 2118219
    [Abstract] [Full Text] [Related]

  • 18. Stimulatory effect of glycine on human growth hormone secretion.
    Kasai K, Kobayashi M, Shimoda SI.
    Metabolism; 1978 Feb 08; 27(2):201-8. PubMed ID: 622050
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone release in unstable diabetes: tests with saline, arginine, glucagon, and epinephrine (author's transl).
    Cremer GM, Molnar GD, Taylor WF, Rosevear JW, Ackerman E.
    Acta Diabetol Lat; 1973 Feb 08; 10(6):1216-35. PubMed ID: 4793673
    [No Abstract] [Full Text] [Related]

  • 20. [Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
    Carducci Artenisio A, Ragonese F, Albanese MC, Alibrando S, Allegra V.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):946-52. PubMed ID: 4463984
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.